Bank of New Hampshire »

United Therapeutics Corporation shares owned by Bank of New Hampshire

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Bank of New Hampshire from 13F filings

Historical chart of Bank of New Hampshire investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Bank of New Hampshire consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Bank of New Hampshire

Quarter filed Position value Share count Share price at filing
2023-12-31 $7.7k 35 219.89
2023-09-30 $7.9k 35 225.86
2023-06-30 $7.7k 35 220.74

More positions owned by Bank of New Hampshire

Apple (AAPL)
Microsoft Corporation (MSFT)
Vanguard Mid Cap ETF Mid Cap Etf (VO)
SPDR Gold Trust Gold Shs (GLD)
iShares Intermediate Govt/Credit ETF Intrm Gov Cr Etf (GVI)
iShares Core S&P 500 ETF Core S&p500 Etf (IVV)
Alphabet Inc CL A Cap Stk Cl A (GOOGL)
Spdr S&p 500 Etf Tr Unit (SPY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
United Parcel Service CL B (UPS)
Amazon (AMZN)
UnitedHealth (UNH)
JPMorgan Chase & Co. (JPM)
Vanguard Ftse Developed Markets ETF Van Ftse Dev Mkt (VEA)
SPDR S&P Midcap 400 ETF Utser1 S&pdcrp (MDY)

View all positions for Bank of New Hampshire

Top funds holding United Therapeutics Corporation

BlackRock
Vanguard Group
Wellington Management Company
venBio Select Advisor
Henderson Group
Citigroup
Dimensional Fund Advisors
AQR Capital Management
LSV Asset Management
Pacer Advisors
Bank of New York Mellon
Norges Bank Investment Management
Charles Schwab Investment Management
Palo Alto Investors
OrbiMed Advisors

View all funds holding United Therapeutics Corporation